What is the efficacy of combination EBRT, chemotherapy and surgery in the treatment of bladder cancer?

Updated: Feb 23, 2021
  • Author: Kara N Babaian, MD, FACS; Chief Editor: Bradley Fields Schwartz, DO, FACS  more...
  • Print

In certain centers, a bladder-preserving strategy for T2-T3 urothelial carcinoma is applied using a combination of external beam radiation, chemotherapy, and endoscopic resection. Survival rates associated with this approach are comparable with those of cystectomy in selected patients. This combination has a widespread application that is limited by the complexity of the protocol, its toxicity, and a high peritreatment mortality rate of 4-5%, mostly due to nadir sepsis from the chemotherapy. In comparison, the mortality rate for most modern cystectomy series is 2-3%.

Did this answer your question?
Additional feedback? (Optional)
Thank you for your feedback!